Cure My Disease

Don't miss your cure!

 Log in / Sign up

Community-Driven TB screening aims to reach vulnerable immigrants

NCT ID NCT07687121

Not yet recruiting Knowledge-focused Sponsor: Universidade Nova de Lisboa Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study works with African and South Asian immigrants to design a tuberculosis (TB) screening program that fits their needs. Researchers will hold workshops with immigrants, community leaders, and doctors to identify barriers and create a screening pathway. Then, they will test the program with 200 immigrants from Angola, Cape Verde, Guinea-Bissau, Mozambique, India, Bangladesh, and Nepal who arrived in Portugal less than five years ago. The goal is to improve TB detection and understand the specific challenges these communities face.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could create a culturally sensitive screening model that improves TB detection in vulnerable immigrant communities.
What could go wrong
This is an early-stage, small study (200 participants) focused on design and feasibility, not a large-scale trial. Results may not apply to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

active tuberculosis latent tuberculosis infection tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUBERCULOSIS TUBERCULOSIS (TB) TUBERCULOSIS ACTIVE TUBERCULOSIS INFECTION, LATENT

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.